Fusion Antibodies (LON:FAB) Stock Price Up 12.2% on Insider Buying Activity

Fusion Antibodies plc (LON:FAB) shares traded up 12.2% during trading on Wednesday following insider buying activity. The stock traded as high as GBX 4.80 ($0.06) and last traded at GBX 4.66 ($0.06). 1,225,806 shares traded hands during mid-day trading, an increase of 10% from the average session volume of 1,114,868 shares. The stock had previously closed at GBX 4.15 ($0.05).

Specifically, insider Adrian Kinkaid acquired 83,728 shares of the company’s stock in a transaction that occurred on Wednesday, October 16th. The stock was acquired at an average price of GBX 4 ($0.05) per share, with a total value of £3,349.12 ($4,373.36).

Fusion Antibodies Stock Performance

The firm has a market cap of £4.67 million, a P/E ratio of -120.00 and a beta of 0.49. The company has a debt-to-equity ratio of 2.40, a quick ratio of 2.36 and a current ratio of 3.87. The company’s 50 day moving average is GBX 3.61 and its 200 day moving average is GBX 3.51.

Fusion Antibodies Company Profile

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services.